GPCR FY 2021 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

GPCRStructure Therapeutics Inc.

$3B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$38M

Net Income

-$40M

EPS (Diluted)

$-1.20

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$111M

Total Liabilities

$176M

Stockholders' Equity

-$65M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$20,034	+100.0%
Operating Income	-$38M	-$16M	-136.6%
Net Income	-$40M	-$16M	-151.6%